ABCL

AbCellera Biologics Inc.

NasdaqAdd to watchlist

Healthcare · Biotechnology

$11.05

−$0.39−3.41%

Delayed · 2026-09-09T20:00:00.000Z · marketstack

Aug 10, 2026$11.05

+$1.71+18.31%over 1M

Day range9% of range

$11.01$11.45

Session

Previous close: $11.44
Open: $11.37
Volume: 2.41M
Avg volume: -
Day high: $11.45
Day low: $11.01

Fundamentals

Visualize fundamentals and more

Market cap: 3.38B
P/E ratio: -
EPS (TTM): -$0.54
Dividend yield: -
Beta: 1.43
Shares outstanding: 305.56M

Source SEC EDGAR · 9/10/2026

Risk factors, year on year

Item 1AFebruary 2026 10-KFebruary 2025as filed.

added: 67
dropped: 74
re-drafted: 142

Out of 314 passages in this year’s Item 1A.

New this year

The various ways we could raise additional capital carry potential risks. If we raise funds by issuing equity securities, dilution to our shareholders would result. Any preferred equity securities issued also would likely provide for rights,

140 more passages, included withBespoke

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like AbCellera Biologics Inc.

Also filed under Biotechnology, ranked by how closely they sit beside ABCL.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc
ARGXARGENX SE

Ask about AbCellera Biologics Inc.

The assistant answers from what ABCL has actually filed: 7 annual reports filed with the SEC and 1 fund that holds it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from ABCL's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding AbCellera Biologics Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with AbCellera Biologics Inc.

Separate the decisions from the paperwork
Every Form 4 ABCL insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about AbCellera Biologics Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.